Cefiderocol Sulfate Tosylate
Tier C — Watch / tradeCefiderocol Sulfate Tosylate
Targets：PBPs
Brand：Fetcroja, Fetroja
Indications (approved)：Urinary tract infection, Pyelonephritis, Bacterial infection, Ventilator-associated pneumonia, Bacterial pneumonia, Hospital-acquired pneumonia, Gram-negative bacterial infection
Regional status
Factories producing this API2
Factories registered as producing this API in our sourcing network (RFQ records + product master), sorted by RFQ activity; the snapshot carries no cost or customer data.
2 producing factories on file — sign in to view the named list (factory details are not shown to guests).
Sign in to view factories →Synthetic routes & intermediates1 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| CEFID-001 | 52009-53-7 | 2-chloro-3,4-dimethoxybenzoic acid |
| CEFID-002 | - | 2-chloro-3,4-dihydroxybenzoic acid |
| CEFID-003 | 137054-45-6 | 4-methoxybenzyl 2-chloro-3,4-bis((4-methoxybenzyl)oxy)benzoate |
| CEFID-004 | 137054-46-7 | 2-chloro-3,4-bis((4-methoxybenzyl)oxy)benzoic acid |
| CEFID-005 | 7154-73-6 | 2-(pyrrolidin-1-yl)ethan-1-amine |
| CEFID-006 | 1225208-44-5 | 2-chloro-3,4-bis((4-methoxybenzyl)oxy)-N-(2-(pyrrolidin-1-yl)ethyl)benzamide |
| CEFID-007 | - | tert-butyl 2-((((E)-1-(2-((tert-butoxycarbonyl)amino)thiazol-4-yl)-2-(((6R,7R)-2-(3,3-diphenylpropanoyl)-3-(iodomethyl)-5-oxido-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-7-yl)amino)-2-oxoethylidene)amino)oxy)-2-methylpropanoate |
| CEFID-008 | - | 1-(((6R,7R)-7-((E)-2-(((1-(tert-butoxy)-2-methyl-1-oxopropan-2-yl)oxy)imino)-2-(2-((tert-butoxycarbonyl)amino)thiazol-4-yl)acetamido)-2-(3,3-diphenylpropanoyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl)methyl)-1-(2-(2-chloro-3,4-bis((4-methoxybenzyl)oxy)benzamido)ethyl)pyrrolidin-1-ium iodide |
Frequently asked questions
What are the approved indications of Cefiderocol Sulfate Tosylate?
Approved indications include: Urinary tract infection, Pyelonephritis, Bacterial infection, Ventilator-associated pneumonia, Bacterial pneumonia, Hospital-acquired pneumonia, Gram-negative bacterial infection.
When does the Cefiderocol Sulfate Tosylate patent expire?
No public expiry year is available for Cefiderocol Sulfate Tosylate yet; this page updates once verified.
How many synthesis routes are recorded for Cefiderocol Sulfate Tosylate?
1 synthesis routes are recorded; the shortest is 6 steps with 264 mg total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Cefiderocol Sulfate Tosylate intermediates?
All intermediates in Cefiderocol Sulfate Tosylate routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.
How do I get a quote for Cefiderocol Sulfate Tosylate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29